Skip to content

Sections

Maps Timeline Graph Cosmos Life Culture Innovation People Climate Trends Art

Browse Dictionary Books Food Places Asteroids Exoplanets Artists Albums Gazetteer Search

© 2026 Vinony · Knowledge from Wikipedia, Wikidata, and 27 public APIs.

Sucroferric oxyhydroxide · Vinony

Home
Chemical pages without ChemSpiderID
Sucroferric oxyhydroxide

🌐Tiếng Việt

English Tiếng Việt العربية 日本語

MedicationQ18386075· pop 6· linked from 17 articles

Sucroferric oxyhydroxide

Also known as Velphoro

pharmaceutical drug

Research

127 papers

Sucroferric Oxyhydroxide.2006
Sucroferric oxyhydroxide for hyperphosphatemia: a review of real-world evidence.Journal of nephrology · 2022
Sucroferric oxyhydroxide for the treatment of hyperphosphatemia.Expert opinion on pharmacotherapy · 2018
A safety evaluation of sucroferric oxyhydroxide for the treatment of hyperphosphatemia.Expert opinion on drug safety · 2021
Efficacy and Safety of Sucroferric Oxyhydroxide Compared with Sevelamer Carbonate in Chinese Dialysis Patients with Hyperphosphataemia: A Randomised, Open-Label, Multicentre, 12-Week Phase III Study.Nephron · 2024

Clinical Trials

5 registered

TERMINATED

Available in 6 languages

Español
日本語
العربية
Odia
Tiếng Việt

via Wikidata sitelinks · CC0

Connections

Categories

Chemical pages without ChemSpiderID Drugs with non-standard legal status Infobox drug articles without a structure image Phosphate binders

Sources

wikipedia.externallinksexternallink
clinicaltrialsclinicaltrials

Velphoro and Impact on the Oral Cavity and Gut Microbiome

RWTH Aachen University · NCT03409757

PHASE3TERMINATED

A Study to Investigate the Safety and Efficacy of PA21 (Velphoro®) and Calcium Acetate (Phoslyra®) in Paediatric and Adolescent Chronic Kidney Disease (CKD) Patients With HyperphosphataemiaVifor Fresenius Medical Care Renal Pharma · NCT02688764

COMPLETED

Non-interventional Study to Investigate the Short and Long Term Real-life Safety, Effectiveness, and Adherence of Velphoro® in Patients With Hyperphosphataemia Undergoing Haemodialysis (HD) or Peritoneal Dialysis (PD)Vifor Fresenius Medical Care Renal Pharma · NCT02687594

PHASE2COMPLETED

The Effect of Phosphate Lowering Using Sucroferric Oxyhydroxide (PA21) on Calcification Propensity of SerumPrim. Priv. Doz. Dr. Daniel Cejka · NCT03010072

PHASE4COMPLETED

Effect of Velphoro on Serum Phosphate and Albumin in Peritoneal Dialysis PatientsUniversity of Colorado, Denver · NCT04046263

via ClinicalTrials.gov

Wikidata facts

Show 1 more fact

defined daily dose: 1.5

Sources (3)

wikidata.org
ema.europa.eu
whocc.no

via Wikidata · CC0

carbohydrate

Entity

large intestine

digital object identifier

calcium carbonate

cardiovascular disease

CAS Registry Number

United States Food and Drug Administration

Anatomical Therapeutic Chemical Classification System

Sign in to save

What links here17 pages

phosphate binder

calcium carbonate

renal osteodystrophy

polystyrene sulfonate

lanthanum carbonate

sodium zirconium cyclosilicate

calcium acetate

aluminum hydroxide

Similar entities

Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).

Entitydist 0.50

succinylmonocholine

Entitydist 0.50

Entitydist 0.53

indoleacetic acid

Entitydist 0.54

aminooxyacetic acid

Entitydist 0.58

Entitydist 0.59

benzyltrimethylammonium hydroxide

Entitydist 0.59

holmium(III) hydroxide

Entitydist 0.60

Hinsberg oxindole synthesis

Entitydist 0.60

Entitydist 0.61

Entitydist 0.61

Bohuslav Brauner

Entitydist 0.61